No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Benzamides / pharmacology
-
Benzamides / therapeutic use
-
Drug Resistance, Neoplasm / genetics
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy*
-
Leukemia, Myeloid, Acute / genetics*
-
Mutation*
-
Niacinamide / analogs & derivatives*
-
Niacinamide / therapeutic use
-
Phenylurea Compounds / therapeutic use*
-
Piperazines / pharmacology
-
Piperazines / therapeutic use
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use
-
Receptor, Platelet-Derived Growth Factor alpha / genetics*
-
Sorafenib
-
Treatment Outcome
-
mRNA Cleavage and Polyadenylation Factors / genetics*
Substances
-
Antineoplastic Agents
-
Benzamides
-
FIP1L1 protein, human
-
Phenylurea Compounds
-
Piperazines
-
Pyrimidines
-
mRNA Cleavage and Polyadenylation Factors
-
Niacinamide
-
Imatinib Mesylate
-
Sorafenib
-
Receptor, Platelet-Derived Growth Factor alpha